Literature DB >> 765184

Effect of oral metoclopramide on gastroesophageal reflux in the post-cibal state.

J Behar, P Biancani.   

Abstract

The effect of oral metoclopramide (15 mg), AlMgOH (30 ml), and placebo on the cumulative duration of gastroesophageal reflux induced by a protein-rich meal was compared in 15 patients with reflux esophagitis. Oral metoclopramide was found to be more effective than AlMgOH in reducing the cumulative duration of reflux after placebo over a 3-hr period. The same dose of oral metoclopramide increased resting lower esophageal sphincter pressures in all 15 patients for at least 1 hr and prevented gastroesophageal reflux after an intragastric acid load (300 ml of O.1 N HCl) in 8 of 10 of these patients. Oral metoclopramide, however, failed to increase the amplitude of esophageal contractions and acid clearing of the distal esophagus. These findings suggest that oral metoclopramide in the dose of 15 mg may be potentially valuable in the management of reflux esophagitis.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 765184

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  8 in total

1.  Postprandial gastro-oesophageal reflux in healthy people.

Authors:  M D Kaye
Journal:  Gut       Date:  1977-09       Impact factor: 23.059

2.  24-hour esophageal pH monitoring before and after medical therapy for reflux esophagitis.

Authors:  D A Lieberman
Journal:  Dig Dis Sci       Date:  1988-02       Impact factor: 3.199

3.  Lack of effect of metoclopramide and domperidone on esophageal peristalsis and esophageal acid clearance in reflux esophagitis. A randomized, double-blind study.

Authors:  L Grande; G Lacima; E Ros; J C García-Valdecasas; J Fuster; J Visa; C Pera
Journal:  Dig Dis Sci       Date:  1992-04       Impact factor: 3.199

4.  L-Dopa inhibits metoclopramide stimulation of the lower esophageal sphincter in man.

Authors:  H W Baumann; A L Sturdevant; R W McCallum
Journal:  Dig Dis Sci       Date:  1979-04       Impact factor: 3.199

Review 5.  Metoclopramide: a review of its pharmacological properties and clinical use.

Authors:  R M Pinder; R N Brogden; P R Sawyer; T M Speight; G S Avery
Journal:  Drugs       Date:  1976       Impact factor: 9.546

6.  Metoclopramide inhibits development of esophageal varices in rat model.

Authors:  M Ohta; M Hashizume; K Tanoue; K Ueno; K Komori; T Ishii; S Kitano; K Sugimachi
Journal:  Dig Dis Sci       Date:  1994-09       Impact factor: 3.199

7.  [Indication for conservative therapy of reflux esophagitis (author's transl)].

Authors:  R Ottenjann
Journal:  Langenbecks Arch Chir       Date:  1978-11

Review 8.  Metoclopramide. An updated review of its pharmacological properties and clinical use.

Authors:  R A Harrington; C W Hamilton; R N Brogden; J A Linkewich; J A Romankiewicz; R C Heel
Journal:  Drugs       Date:  1983-05       Impact factor: 9.546

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.